AllianceBernstein
ARCT icon

AllianceBernstein’s Arcturus Therapeutics ARCT Stock Holding History

AllianceBernstein’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$272K Buy
35,280
+7,560
+27% +$59.6K ﹤0.01% 3031
2026
Q1 		$170K Hold
27,720
– – ﹤0.01% 3087
2025
Q4 		$170K Sell
27,720
-3,400
-11% -$36.7K ﹤0.01% 3098
2025
Q3 		$574K Hold
31,120
– – ﹤0.01% 2606
2025
Q2 		$405K Buy
31,120
+8,320
+36% +$98.4K ﹤0.01% 2770
2025
Q1 		$241K Sell
22,800
-2,610
-10% -$41.4K ﹤0.01% 2860
2024
Q4 		$431K Hold
25,410
– – ﹤0.01% 2702
2024
Q3 		$590K Hold
25,410
– – ﹤0.01% 2580
2024
Q2 		$619K Hold
25,410
– – ﹤0.01% 2549
2024
Q1 		$858K Hold
25,410
– – ﹤0.01% 2345
2023
Q4 		$801K Hold
25,410
– – ﹤0.01% 2383
2023
Q3 		$649K Sell
25,410
-55,660
-69% -$1.71M ﹤0.01% 2441
2023
Q2 		$2.33M Buy
81,070
+58,270
+256% +$1.59M ﹤0.01% 1821
2023
Q1 		$547K Hold
22,800
– – ﹤0.01% 2524
2022
Q4 		$387K Hold
22,800
– – ﹤0.01% 2768
2022
Q3 		$338K Sell
22,800
-3,300
-13% -$55.4K ﹤0.01% 2814
2022
Q2 		$411K Hold
26,100
– – ﹤0.01% 2762
2022
Q1 		$704K Hold
26,100
– – ﹤0.01% 2546
2021
Q4 		$966K Hold
26,100
– – ﹤0.01% 2483
2021
Q3 		$1.25M Sell
26,100
-4,000
-13% -$179K ﹤0.01% 2417
2021
Q2 		$1.02M Hold
30,100
– – ﹤0.01% 2524
2021
Q1 		$1.24M Hold
30,100
– – ﹤0.01% 2326
2020
Q4 		$1.31M Buy
30,100
+14,000
+87% +$948K ﹤0.01% 2190
2020
Q3 		$691K Sell
16,100
-600
-4% -$29.8K ﹤0.01% 2354
2020
Q2 		$781K Buy
+16,700
New +$576K ﹤0.01% 2338

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

AllianceBernstein's ARCT Position: Q2 2026 in Review

AllianceBernstein increased its Arcturus Therapeutics (ARCT) stake by 27% in Q2 2026, buying an estimated $59.6K and bringing the position to 35,280 shares worth $272K. The position accounts for ﹤0.01% of the portfolio, ranked #3031.

AllianceBernstein first reported a position in ARCT in Q2 2020 and has held it in 25 quarters since. The position peaked at $2.33M in Q2 2023. 135 funds tracked by Wall St. Rank hold ARCT as of Q2 2026.

  • AllianceBernstein held 35,280 shares of Arcturus Therapeutics worth $272K as of Q2 2026.
  • AllianceBernstein bought 7,560 Arcturus Therapeutics shares in Q2 2026, an estimated $59.6K.
  • Arcturus Therapeutics made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #3031 holding.
  • AllianceBernstein first reported a position in Arcturus Therapeutics in Q2 2020 and has held it in 25 quarters since.
  • AllianceBernstein's Arcturus Therapeutics position peaked at $2.33M in Q2 2023.
  • 135 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.